|
TARS Tarsus Pharmaceuticals Inc 1819790 |
| Balance Sheet |
|
Current Assets
|
$537,229,000.00 |
|
Assets
|
$581,135,000.00 |
|
Current Liabilities
|
$143,508,000.00 |
|
Liabilities
|
$232,184,000.00 |
|
Equity
|
$348,951,000.00 |
|
Shares Out
|
43021312.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-24,652,000.00 |
|
Investing Cash Flow
|
$-58,562,000.00 |
| Market Analysis |
Market Cap
|
$2,561,488,916.48 |
|
Price
|
$59.49 |
|
BVPS
|
8.11 |
|
PB
|
7.34 |
|
EPS
|
-0.16 |
|
PS
|
4.04 |
|
FCF
|
$-30,470,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:21 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:17 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-23 |
-0.20 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-06 |
-0.16 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-0.48 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
-0.30 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TARS documents filed with the SEC.
TARS Filings
Clear
